Skip to main content
All alerts

HEALTHCARE • NATIONWIDE

Is this active?Status: CURRENTRecall in effect now — one specific lot is affected.

Chlorthalidone Blood Pressure Pills Recalled Again: Check Your Bottle

If you take chlorthalidone for high blood pressure, take a moment to check your prescription bottle.

LAST VERIFIED:

Published:

EVIDENCE: STRONG
PRODUCT
Chlorthalidone Tablets, USP, 25 mg
LOT/BATCH
RISA24002
NDC
64980-599-01
EXPIRATION
April 2027

If you take chlorthalidone for high blood pressure, take a moment to check your prescription bottle.

More than 13,500 bottles of chlorthalidone 25 mg tablets have been recalled nationwide because the tablets failed a test of how they dissolve. This is the second chlorthalidone recall from the same manufacturer this year for the same problem.

Here’s what you need to know.

What is chlorthalidone?

Chlorthalidone is a prescription diuretic, sometimes called a “water pill.” It is commonly used to treat high blood pressure and can also be used to reduce excess fluid associated with certain medical conditions.

For someone taking it to control blood pressure, getting the intended dose consistently matters.

What exactly has been recalled?

The September 2026 recall involves:

  • Chlorthalidone Tablets, USP, 25 mg
  • 100 tablets per bottle
  • NDC: 64980-599-01
  • Lot/batch: RISA24002
  • Expiration date: April 2027
  • 13,567 bottles
  • Distributed nationwide
  • Manufactured by Inventia Healthcare Limited
  • Distributed in the United States by Rising Pharma Holdings, Inc.

The manufacturer initiated the recall on September 3, 2026. The FDA classified it as a Class II recall on September 17.

The most important thing is the lot number.

If your bottle says RISA24002 and has an expiration date of 04/2027, contact your pharmacist or healthcare provider for instructions about getting a replacement.

If your pharmacy transferred the medication into an orange prescription bottle, the original lot number may not appear on the label. In that case, your pharmacist can determine which lot you received.

What does “failed dissolution specifications” mean?

This sounds more alarming than it necessarily is.

Before a tablet is approved and distributed, manufacturers test how it breaks down and releases its active ingredient. Dissolution testing helps determine whether the medicine is releasing the drug as expected.

A failure means the affected tablets did not meet the required dissolution specifications. That could affect how consistently the medication releases its active ingredient and therefore how predictably it works.

It does not mean that every tablet contains the wrong amount of medication, or that everyone who took one will be harmed. A laboratory dissolution failure cannot tell us exactly how much medication any individual patient absorbed.

This has happened before

This isn't the first chlorthalidone recall this year.

In June, Inventia recalled approximately 11,460 bottles of 25 mg chlorthalidone for the same reason: failed dissolution specifications.

That earlier recall involved lots RISA24001 and RISB24002, both with an April 2027 expiration date. The September recall involves the additional RISA24002 lot. Together, the two recalls affect more than 25,000 bottles.

What does a Class II recall mean?

The FDA uses three main recall classifications.

Class I is the most serious and involves a reasonable probability of serious health consequences or death.

Class II means use of the product may cause temporary or medically reversible health consequences, or that the probability of serious health consequences is considered remote.

Class III means use of the product is not likely to cause adverse health consequences.

This chlorthalidone recall is Class II.

That is important—but it doesn't mean the FDA believes everyone taking the recalled tablets is in immediate danger.

Don't stop taking it on your own

This may be the most important part of the alert.

If you discover that you have the recalled lot, don't simply stop taking your blood-pressure medication without talking to your pharmacist or healthcare provider.

The FDA specifically notes that with Class II and III drug recalls, patients can generally continue taking the medicine unless the manufacturer or FDA provides different instructions. In some situations, abruptly stopping a medication can itself create a health risk.

Instead:

  • Check your bottle.
  • If the lot is RISA24002, contact your pharmacist or prescriber.
  • Ask about obtaining an unrecalled replacement supply.
  • Follow their instructions about what to do with the recalled medication.
  • Continue monitoring your blood pressure as you normally would, unless your healthcare professional tells you otherwise.

Why this matters

Blood pressure often doesn't give you any warning when it rises.

That's one reason medications such as chlorthalidone can be important even when you feel perfectly fine. If a medication isn't performing as intended, the problem may not announce itself with an obvious symptom.

The purpose of a recall is to catch a potential quality problem before it becomes a bigger problem.

So this isn't a reason to panic.

It's a reason to check the bottle.

The Watchdog Takeaway

If you take chlorthalidone, check your bottle for lot RISA24002 and an April 2027 expiration date. If it matches, don't stop the medication on your own—contact your pharmacist or healthcare provider about getting a replacement.

Evidence: Strong

This is an FDA-classified Class II recall of a specific lot of chlorthalidone 25 mg tablets (lot RISA24002) for failed dissolution specifications, initiated by the manufacturer on September 3, 2026 and classified by the FDA on September 17, 2026. Recall classifications and patient guidance come from the U.S. Food and Drug Administration. This article is general information, not personal medical advice.

Official sources

About this information

Senior Life Watchdog provides general public information and is not a government agency, law firm, financial advisory service, or healthcare provider. This information is intended to help readers understand changes and locate official resources. Rules can change and individual eligibility depends on your circumstances. Always verify important information with the appropriate government agency or qualified professional before making financial, legal, or healthcare decisions.

Last verified: September 30, 2026

We’ll update this page when official information changes.

VERIFY THE INFORMATION

Source:
U.S. Food and Drug Administration
Official publication:
Enforcement Report — Chlorthalidone Tablets, USP, 25 mg recall (lot RISA24002)
Last verified by Senior Life Watchdog:
VIEW OFFICIAL SOURCE(opens in a new tab)

KNOW SOMEONE WHO SHOULD SEE THIS?

If this information could help someone you know, share this alert with them.

Email

GET USEFUL INFORMATION, NOT NOISE.

Important changes. New research. Practical ideas. Things worth knowing as you get more seasoned.

One useful email a week. Signing up also gives you a chance to ask questions.

Your email address is used only for Senior Life Watchdog communications. We do not sell or share subscriber information.

See something that needs correction? Let us know.